Human Papillomavirus in Menstrual Blood
NCT01506128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19
Last updated 2013-03-05
Summary
The investigators tried to know whether a virus causing cervical cancer could be detected in menstrual blood and to set up a experimental setting to detect the virus.
Conditions
- Human Papillomavirus
Interventions
- OTHER
-
Collecting a Pad used at the first menstrual period after enrollment
Collecting a Pad used at the first menstrual period after enrollment
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study
NCT03409471 ·Status: UNKNOWN
-
Cervical Cancer Screening Strategies
NCT05309122 ·Status: UNKNOWN
-
Infectious Risk of Vaginal Ultrasound Examination: Evaluation and Modeling From Human Papillomavirus (HPV)
NCT02659072 ·Status: COMPLETED
-
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
NCT04072913 ·Status: COMPLETED ·Phase: NA
-
HPV in Blood Samples From Cervical Cancer Patients.
NCT03749720 ·Status: COMPLETED ·Phase: NA
-
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
NCT01190176 ·Status: COMPLETED ·Phase: PHASE3
-
Intraoperative HPV Testing Evaluation
NCT04190472 ·Status: UNKNOWN
-
Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283 ·Status: ACTIVE_NOT_RECRUITING
-
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix
NCT04333212 ·Status: COMPLETED ·Phase: NA
-
Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects
NCT00937950 ·Status: COMPLETED ·Phase: PHASE3
-
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
NCT01837693 ·Status: COMPLETED ·Phase: NA
-
Detecting HPV DNA in Anal and Cervical Cancers
NCT04857528 ·Status: RECRUITING
-
Significance of the High-risk Hpv Viral Load
NCT00682812 ·Status: COMPLETED ·Phase: NA
-
Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer
NCT01854983 ·Status: COMPLETED
-
The Human Papilloma Virus Effect on Sexual Life
NCT03837028 ·Status: COMPLETED
-
Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm
NCT01511328 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions
NCT00872937 ·Status: UNKNOWN
-
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
NCT06115772 ·Status: RECRUITING
-
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood
NCT06261879 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
NCT00877877 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population
NCT00673192 ·Status: UNKNOWN ·Phase: NA
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
NCT00481767 ·Status: COMPLETED ·Phase: PHASE3
-
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
NCT00435214 ·Status: COMPLETED
-
HPV-based Screening Among Women 23-29 Years of Age
NCT05229679 ·Status: RECRUITING ·Phase: NA